620 related articles for article (PubMed ID: 18589141)
1. Heparin-induced thrombocytopenia after liver transplantation.
Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
3. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of heparin-induced thrombocytopenia].
Wang JH; Wang CY; Xie R; Che DH; Jia RC; Ju W; Miao MJ; Wang H; Jiang Y; Tong DX
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):115-7. PubMed ID: 21429379
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
[TBL] [Abstract][Full Text] [Related]
6. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
Ban-Hoefen M; Francis C
Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
[TBL] [Abstract][Full Text] [Related]
7. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
Warkentin TE; Roberts RS; Hirsh J; Kelton JG
Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
[TBL] [Abstract][Full Text] [Related]
8. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
[TBL] [Abstract][Full Text] [Related]
9. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
[TBL] [Abstract][Full Text] [Related]
12. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
13. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
Junqueira DR; Perini E; Penholati RR; Carvalho MG
Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
[TBL] [Abstract][Full Text] [Related]
14. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
[TBL] [Abstract][Full Text] [Related]
15. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
16. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases.
Refaai MA; Van Cott EM; Laposata M
Am J Clin Pathol; 2003 Apr; 119(4):497-504. PubMed ID: 12710122
[TBL] [Abstract][Full Text] [Related]
17. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
Franke J; Schaeper O; Kayser R; Mahlfeld K
Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
[TBL] [Abstract][Full Text] [Related]
18. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
Fretschner R; Dietrich K; Unertl K; Greinacher A
Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.
Sturtevant JM; Pillans PI; Mackenzie F; Gibbs HH
Intern Med J; 2006 Jul; 36(7):431-6. PubMed ID: 16780449
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
